Larvol Delta - aTyr-Pharma-Announces-Positive-Biomarker-Data-from-Phase-2-Clinical-Trial-of-ATYR1923-Demonstrating-AntiInflammatory-Effects-in-COVID19-Patients-with-Severe-Respiratory-Complications

Stalaris (ATYR1923) - aTyr Pharma, Kyorin

https://www.globenewswire.com/news-release/2021/03/15/2192786/0/en/aTyr-Pharma-Announces-Positive-Biomarker-Data-from-Phase-2-Clinical-Trial-of-ATYR1923-Demonstrating-Anti-Inflammatory-Effects-in-COVID-19-Patients-with-Severe-Respiratory-Complicat.html

Mar 15, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next